MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$26K
Net Income
-$3,788K
Net Profit Margin
-14569.23%
EPS
-$0.43
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Total revenues
26
22
26
25
Production costs
5
4
68
10
Research and development
589
482
607
1,174
General and administrative
2,945
1,762
1,798
1,487
Issuance cost
-
-
433
-
Total costs and expenses
3,539
2,248
2,473
2,671
Loss on issuance of warrants
-
-
-3,977
0
Operating loss
-3,513
-2,226
-2,447
-2,646
Gain (loss) on investments
-1
-1
-1
-9
Interest and other income
21
8
3,052
10
Interest expense and other finance costs
295
304
148
149
Loss on change in fair value of warrant liability
-
468
-670
-
Loss on issuance of warrants
-
32
-
-
Net loss
-3,788
-3,023
-3,284
-2,794
Basic EPS
-0.43
-0.69
1.57
-3.68
Diluted EPS
-0.43
-0.69
1.57
-3.68
Basic Average Shares
17,118,695
4,351,449
2,093,446
759,289
Diluted Average Shares
17,118,695
4,351,449
2,093,446
759,289
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$3,788K
(-35.58%↓ Y/Y)
Interest and other income
$21K
(110.00%↑ Y/Y)
Operating loss
-$3,513K
(-32.77%↓ Y/Y)
Interest expense and
other finance costs
$295K
(97.99%↑ Y/Y)
Total revenues
$26K
(4.00%↑ Y/Y)
Gain (loss) on
investments
-$1K
(88.89%↑ Y/Y)
Total costs and
expenses
$3,539K
(32.50%↑ Y/Y)
General and
administrative
$2,945K
(98.05%↑ Y/Y)
Research and development
$589K
(-49.83%↓ Y/Y)
Production costs
$5K
(-50.00%↓ Y/Y)
Buy us a coffee
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. (AIM)